Contineum Therapeutics Inc
CTNM12.240USD
-0.020-0.16%
Market hours （ET）Quotes delayed by 15 min
357.19MMarket Cap
LossP/E TTM
Contineum Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
-2.18
-341.52%
Analyst Rating
STRONG BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of -100.00%.
What is the Earnings Per Share (EPS) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.184, with a year-on-year change of -341.52%.
What is the net income of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its net income was -42.26M, with a year-on-year change of -285.99%.
What is the net margin of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -64.95%, with a year-on-year change of --.
What is the Return on Assets (ROA) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -24.62%, with a year-on-year change of -198.09%.
What is the operating profit of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its operating profit was -50.89M, with a year-on-year change of -416.56%.
What are the current assets of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its current assets were 206.39M, with a year-on-year change of 61.61%.
What are the total assets of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its total assets of Contineum Therapeutics Inc were 212.85M, with a year-on-year change of 63.24%.
What are the total liabilities of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its total liabilities of Contineum Therapeutics Inc were 14.78M, with a year-on-year change of 159.22%.
What is the total equity of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its total equity of Contineum Therapeutics Inc was 198.07M, with a year-on-year change of 58.85%.
What is the net operating income of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its net operating income of Contineum Therapeutics Inc was -42.26M, with a year-on-year change of -285.99%.
What is the net investment of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its net investment of Contineum Therapeutics Inc was -69.74M, with a year-on-year change of -6.36%.
What is the net financing of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2024 earnings report, its net financing of Contineum Therapeutics Inc was 109.00M, with a year-on-year change of 94.03%.
